Xtrackers Stoxx Europe 600 UCITS ETF (ETR:XSX7)
| Assets | 978.29M |
| Expense Ratio | 0.18% |
| PE Ratio | n/a |
| Dividend (ttm) | 2.49 |
| Dividend Yield | 2.75% |
| Ex-Dividend Date | Feb 18, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| 1-Year Return | +11.85% |
| Volume | n/a |
| Open | 91.52 |
| Previous Close | 92.13 |
| Day's Range | 91.52 - 91.52 |
| 52-Week Low | 71.85 |
| 52-Week High | 98.29 |
| Beta | n/a |
| Holdings | 658 |
| Inception Date | Mar 8, 2023 |
About XSX7
Xtrackers Stoxx Europe 600 UCITS ETF is an exchange traded fund launched by Deutsche Asset & Wealth Management Investment S.A. The fund is managed by State Street Global Advisors Limited. It invests in public equity markets of Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of STOXX Europe 600 Index, by employing representative sampling methodology. It was formerly known as db x-trackers - Stoxx Europe 600 UCITS ETF (DR). Xtrackers Stoxx Europe 600 UCITS ETF was formed on January 20, 2009 and is domiciled in Luxembourg.
Performance
XSX7 had a total return of 11.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.09%.
Top 10 Holdings
19.20% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 3.61% |
| Roche Holding AG | ROC1.L | 2.14% |
| Novartis AG | NOVN | 2.07% |
| AstraZeneca PLC | AZN | 2.07% |
| HSBC Holdings plc | HSBA | 2.06% |
| Nestlé S.A. | NESN | 1.80% |
| Shell plc | SHEL | 1.52% |
| Siemens Aktiengesellschaft | SIE | 1.40% |
| SAP SE | SAP | 1.31% |
| Banco Santander, S.A. | SAN | 1.21% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Feb 18, 2026 | €0.3347 | Mar 5, 2026 |
| Nov 19, 2025 | €0.3156 | Dec 4, 2025 |
| Aug 20, 2025 | €1.3361 | Sep 4, 2025 |
| May 21, 2025 | €0.5055 | Jun 5, 2025 |
| Feb 19, 2025 | €0.2955 | Mar 6, 2025 |
| Nov 13, 2024 | €0.3113 | Nov 29, 2024 |